p16 hypermethylation during gastric carcinogenesis of Wistar rats by N-methyl-N′-nitro-N-nitrosoguanidine

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 535, Issue 1, 2003, Pages 73-78

  Bai, Hua ^a   Gu, Liankun ^a   Zhou, Jing ^a   Deng, Dajun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Carcinogen; CpG island; Gastric carcinogenesis; Methylation; N Nitroso compound; p16; Wistar rat

Indexed keywords

METHYLNITRONITROSOGUANIDINE; PROTEIN P16;

ADENOMA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CARCINOGENESIS; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISSECTION; DYSPLASIA; GASTRITIS; IMMUNOHISTOCHEMISTRY; METHYLATION; NONHUMAN; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RAT STRAIN; SAMPLE; STOMACH CARCINOMA; STOMACH EPITHELIUM; STOMACH LESION;

ANIMALS; BASE SEQUENCE; CARCINOGENS; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION; GENE SILENCING; GENES, P16; METHYLNITRONITROSOGUANIDINE; RATS; RATS, WISTAR; STOMACH NEOPLASMS;

RATTUS NORVEGICUS;

EID: 0037419739     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(02)00288-7     Document Type: Article

References (19)

1. Tahara E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol. 119:1993;265-272.
2. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., Issa J.P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72:1998;141-196.
3. Watt P.M., Kumar R., Kess U.R. Promoter demethylation accompanies reactivation of the HOX11 proto-oncogenes in leukemia. Genes Chromosomes Cancer. 29:2000;371-377.
4. Tsujiuchi T., Tsutsumi M., Sasaki Y., Takahama M., Konishi Y. Hypomethylation of CpG sites and c-myc gene overexpression in hepatocellular carcinomas, but not hyperplastic nodules, induced by a choline-deficient L-amino acid-defined diet in rats. Jpn. J. Cancer Res. 90:1999;909-913.
5. Lee Y.Y., Kang S.H., Seo J.Y., Jung C.W., Lee K.U., Choe K.J., Kim B.K., Kim N.K., Koeffler H.P., Bang Y.J. Alterations of p16 and p15 genes in gastric carcinomas. Cancer. 80:1997;1889-1896.
6. Herman J.G., Latif F., Weng Y., Letman M.I., Zbar B., Liu S., Samid D., Duan D.S., Gnarra J.R., Linehan W.M., Baylin S.B. Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA. 91:1994;9700-9704.
7. Yoshiura K., Kanai Y., Ochiai A., Shimoyama Y., Sugimura T., Hirohashi S. Silencing of the E-cadherin invasion suppressor gene by CpG methyltion in human carcinoma. Proc. Natl. Acad. Sci. USA. 92:1995;7416-7419.
8. Herman J.G., Merlo A., Mao L., Lapidus R.G., Issa J.P., Davidson N.E., Sidrasky D., Baylin S.B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:1995;4525-4530.
9. Belinsky S.A., Nikula K.J., Herman J.G., Palmisano W.A., Michels R., Saccomanno G., Gabrielson E., Baylin S.B. Aberrant methylation of p16 is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. USA. 96:1998;11891-11896.
10. Jang T.J., Kim D.I., Shin Y.M., Chang H.K., Yang C.H. p16(INK4a) promoter hypermethylation of non-tumorous tissue adjacent to gastric cancer is correlated with glandular atrophy and chronic inflammation. Int. J. Cancer. 93:2001;629-634.
11. Deng D.J., Zhu S.X., Chen Q., Zhang R.F. Induction of gastric adenocarcinoma in adult Wistar rats following neonatal exposure to MNNG and neoplastic transforming activity of DNA of the induced cancer. Chin. J. Pathol. 23:1994;293-295.
12. Herman J.G., Graff J.R., Myöhänen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA. 93:1996;9821-9826.
13. Igaki H., Sadaki H., Tachimori Y., Kato H., Watanabe H., Kimura T., Harada Y., Sugimura T., Terada M. Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract. Cancer Res. 55:1995;3421-3423.
14. Swafford D.S., Middleton S.K., Palmisano W.A., Nikula K.J., Tesfaigzi J., Baylin S.B., Herman J.G., Belinsky S.A. Frequent aberrant methylation of p16INK4a in primary rat lung tumors. Mol. Cell Biol. 17:1997;1366-1374.
15. Deng D.J., Gu L.K., Zhu S.X., Chen Q., Zhou J. Expression of oncogenes during chemical gastrocarcinogenesis in rats. Chin. J. Dig. 16:1996;46s-49s.
16. Mirella G.Z., Christian M.B., Allen S.Y., Tudung N., Robert W.B., Tan M.V., Peter A.J. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissue correlates with gene silencing. Cancer Res. 55:1995;4531-4535.
17. Hsieh C.J., Klump B., Holzmann K., Borchard F., Michael G., Rainer P. Hypermethylation of the p16 promoter in colectomy specimens of patients with long standing and extensive ulcerative colitis. Cancer Res. 58:1998;3842-3845.
18. Deng D., Deng G., Smith M.F., Zhou J., Xin H., Powell S.M., Lu Y. Simultaneous detection of CpG methylation and single nucleotide polymorphism (SNP) by denaturing high performance liquid chromatography (DHPLC). Nucleic Acids Res. 30:2002;13e.
19. D. Deng, W. El-Rifai, J. Ji, B. Zhu, P. Trampont, J. Li, M.F. Smith, S.M. Powell, Hypermethylation of metallothionein-3 CpG island in gastric carcinoma, Carcinogenesis 24 (2003), in press.